article_metadata: Mark Reedy Shirisha Jonnalagadda Komaraiah Palle
article_metadata: 10.3389/pore.2021.1609922
article_metadata: Pathol Oncol Res
article_metadata: 2021 Dec 20;27:1609922.
article_metadata: human papilloma virus high-risk variant immunotherapy intratumoral injection quadrivalent hpv-l1 vaccine radiation refractory squamous cell carcinoma toll-like receptor 7 agonist
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/34987310/
article_metadata: Antineoplastic Agents / therapeutic use Carcinoma, Squamous Cell / therapy Genital Neoplasms, Female / therapy Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 / therapeutic use Imiquimod / therapeutic use
article_metadata: Antineoplastic Agents / therapeutic use Carcinoma, Squamous Cell / therapy Genital Neoplasms, Female / therapy Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 / therapeutic use Imiquimod / therapeutic use Case Reports Adult Aged, 80 and over Carcinoma, Squamous Cell / pathology Carcinoma, Squamous Cell / virology Female Genital Neoplasms, Female / pathology Genital Neoplasms, Female / virology Humans Neoplasm Recurrence, Local / therapy Papillomavirus Infections / complications Papillomavirus Infections / therapy Salvage Therapy / methods Toll-Like Receptor 7 / agonists Antineoplastic Agents Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 TLR7 protein, human Toll-Like Receptor 7 Imiquimod
article_metadata: PMC8720759
article_metadata: 34987310
article_metadata: Case Report: Intra-Tumoral Vaccinations of Quadrivalent HPV-L1 Peptide Vaccine With Topical TLR-7 Agonist Following Recurrence: Complete Resolution of HPV-HR-Associated Gynecologic Squamous Cell Carcinomas in Two Patients
article_metadata: 2021